ALBT Avalon GloboCare Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: ALBT

Price (delayed)

$0.4045

Market cap

$4.49M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.41

Enterprise value

$12.6M

Highlights
The revenue has contracted by 24% from the previous quarter but it has grown by 6% YoY
The net income has decreased by 17% YoY but it has increased by 11% from the previous quarter
Avalon GloboCare's gross margin has shrunk by 140% QoQ and by 25% YoY
Avalon GloboCare's gross profit has plunged by 131% from the previous quarter and by 32% YoY
Sector: Healthcare
Industry: Medical Care Facilities
Peers: OPGN NEO

Key stats

What are the main financial stats of ALBT
Market
Shares outstanding
11.1M
Market cap
$4.49M
Enterprise value
$12.6M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.73
Price to sales (P/S)
4.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.13
Earnings
Revenue
$959,516
EBIT
-$13.24M
EBITDA
-$12.93M
Free cash flow
-$5.59M
Per share
EPS
-$1.41
Free cash flow per share
-$0.51
Book value per share
$0.55
Revenue per share
$0.09
TBVPS
$1.84
Balance sheet
Total assets
$20.33M
Total liabilities
$14.28M
Debt
$8.42M
Equity
$6.05M
Working capital
-$7.03M
Liquidity
Debt to equity
1.39
Current ratio
0.1
Quick ratio
0.05
Net debt/EBITDA
-0.63
Margins
EBITDA margin
-1,347.4%
Gross margin
-7.6%
Net margin
-1,558.2%
Operating margin
-1,484.8%
Efficiency
Return on assets
-58.9%
Return on equity
-123.6%
Return on invested capital
-50.3%
Return on capital employed
-105.6%
Return on sales
-1,379.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALBT stock price

How has the Avalon GloboCare stock price performed over time
Intraday
1.13%
1 week
-1.34%
1 month
-13.94%
1 year
-69.36%
YTD
-16.25%
QTD
-13.94%

Financial performance

How have Avalon GloboCare's revenue and profit performed over time
Revenue
$959,516
Gross profit
-$72,658
Operating income
-$14.25M
Net income
-$14.95M
Gross margin
-7.6%
Net margin
-1,558.2%
Avalon GloboCare's gross margin has shrunk by 140% QoQ and by 25% YoY
Avalon GloboCare's gross profit has plunged by 131% from the previous quarter and by 32% YoY
ALBT's operating income is down by 47% year-on-year but it is up by 10% since the previous quarter
ALBT's operating margin is down by 38% year-on-year and by 18% since the previous quarter

Growth

What is Avalon GloboCare's growth rate over time

Valuation

What is Avalon GloboCare stock price valuation
P/E
N/A
P/B
0.73
P/S
4.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.13
The EPS has grown by 11% since the previous quarter but it has declined by 7% year-on-year
The stock's price to book (P/B) is 98% less than its 5-year quarterly average of 30.4 but 9% more than its last 4 quarters average of 0.7
The equity has dropped by 70% year-on-year and by 18% since the previous quarter
The stock's price to sales (P/S) is 90% less than its 5-year quarterly average of 50.4 and 43% less than its last 4 quarters average of 8.5
The revenue has contracted by 24% from the previous quarter but it has grown by 6% YoY

Efficiency

How efficient is Avalon GloboCare business performance
The return on sales has declined by 37% year-on-year and by 13% since the previous quarter
ALBT's return on assets is up by 15% year-on-year
ALBT's return on equity is down by 15% since the previous quarter but it is up by 13% year-on-year
ALBT's ROIC is up by 11% YoY and by 6% QoQ

Dividends

What is ALBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALBT.

Financial health

How did Avalon GloboCare financials performed over time
The company's total assets is 42% higher than its total liabilities
Avalon GloboCare's quick ratio has shrunk by 75% YoY and by 29% QoQ
The current ratio has dropped by 63% year-on-year and by 23% since the previous quarter
The company's debt is 39% higher than its equity
The equity has dropped by 70% year-on-year and by 18% since the previous quarter
The company's debt has surged by 51% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.